Commercial Credit Report for Apollo Endosurgery, Inc.

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Apollo Endosurgery, Inc. is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Apollo Endosurgery, Inc.

1120 South Capital Of Tx Hwy

Building 1 Suite 300

Phone: (512) 279-5100p:512 279-5100

WEST LAKE HILLS, TX 78746-6464 United States

Fax: (302) 674-5266f:302 674-5266

This company was Merged or Acquired on 4/4/2023.

This company ceased filing statements with the SEC on 4/14/2023.

This company is no longer actively traded on any major stock exchange.

This is a Subsidiary, click here for the Parent Company

Business Summary

Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	Yes	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2022	12/31/2022	Yes	Yes	-	-	Yes

Industries

SIC Code	Description
2836	Biological products, except diagnostic substances
3841	Surgical and medical instruments and apparatus
6770	Blank checks

Officers and Directors

Title	Name	Age	Title Date	Start Date
Independent Chairman of the Board	John R.Barr	64	6/6/2019	3/25/2019
President, Chief Executive Officer, Director	Charles S.McKhann	53	3/1/2021	3/1/2021
Chief Financial Officer, Secretary	Jeffrey G.Black	53	8/1/2021	8/1/2021
7 additional Officers and Directors records available in full report.

Business Names

Business Name
APEN
Lpath Therapeutics Inc.
Neighborhood Connections, Inc.

General Information

Number of Employees:	281	(As of 12/31/2022)
Outstanding Shares:	57,971,919	(As of 3/15/2023)
Shareholders:	93
Stock Exchange:	NASD
Federal Tax Id:	161630142
Fax Number:	(302) 674-5266

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN